Guidance Recipients

Overview

• Venous thromboembolism (VTE) is a chronic disease. The most promising therapy is catheter-assisted administering of drugs (thrombolytic agents) plus ultrasound treatment. Clinically speaking, however, patients often need to stay in bed for days or even one week. Inconvenient as it is, long-term use of thrombolytic agents also tends to incur intracerebral hemorrhage, strokes, and tissue hemorrhage throughout the body.
• The team has thus developed a solution that combines ultrasound vortex technology and catheter-assisted drug administering. Ultrasound shearing and pushing helps not only debilitate thrombi but also get thrombolytic agents across more effectively, thereby enhancing thrombolytic efficacy.
• Enhance thrombolytic efficacy, shorten therapeutic duration, and mitigate such side effects as tissue hemorrhage and strokes.